Korean J Med.  2013 Oct;85(4):439-444.

Diffuse Alveolar Hemorrhage after Adalimumab Treatment of Rheumatoid Arthritis

Affiliations
  • 1Department of Internal Medicine, Soonchunhyang University College of Medicine, Seoul, Korea. healthyra@schmc.ac.kr
  • 2Department of Internal Medicine, Chosun University College of Medicine, Gwangju, Korea.

Abstract

Diffuse alveolar hemorrhage (DAH) is a life-threatening condition involving hemorrhage originating in the pulmonary microvasculature. The clinical syndrome is characterized by hemoptysis, hypoxemic respiratory failure, low-grade fever, and diffuse pulmonary infiltrates. The majority of cases of DAH are caused by pulmonary renal syndromes, connective tissue disorders, and drugs. Here, we present a case of DAH associated with adalimumab treatment in a patient with rheumatoid arthritis.

Keyword

Alveolar hemorrhage; Adalimumab; Rheumatoid arthritis

MeSH Terms

Antibodies, Monoclonal, Humanized
Arthritis, Rheumatoid
Connective Tissue
Fever
Hemoptysis
Hemorrhage
Humans
Microvessels
Respiratory Insufficiency
Adalimumab
Antibodies, Monoclonal, Humanized
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr